Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis

American Journal of Gastroenterology

Volumn 102, Issue 3, 2007, Pages 589-597

  Aldhous, Marian C ^a,b   Drummond, Hazel E ^a   Anderson, Niall ^b   Baneshi, Mohammadreza Reza ^c   Smith, Linda A ^a   Arnott, Ian D R ^a   Satsangi, Jack ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CIGARETTE SMOKING; COHORT ANALYSIS; COLONOSCOPY; CONFIDENCE INTERVAL; DATA ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HAZARD RATIO; HISTOLOGY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SMOKING; SMOKING HABIT; ULCERATIVE COLITIS;

EID: 33847273087     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01065.x     Document Type: Article

References (54)

1. Satsangi J, Morecroft J, Shah NB, et al. Genetics of inflammatory bowel disease: Scientific and clinical implications. Best Prac Res Clin Gastroenterol 2003;17:3-18.
2. Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: The role of environmental factors. Autoimm Rev 2004;3:394-400.
3. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999;11:648-56.
4. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-33.
5. Langholz E, Munkholm P, Davidsen M, et al. Changes in extent of ulcerative colitis: A study on the course and prognostic factors. Scand J Gastroenterol 1996;31:260-6.
6. Moum B, Ekbom A, Vatn M, et al. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol 1999;94:1564-9.
7. Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993;38:1137-46.
8. Ayres RC, Gillen CD, Walmsley RS, et al. Progression of ulcerative proctosigmoiditis: Incidence and factors influencing progression. Eur J Gastroenterol Hepatol 1996;8:555-8.
9. Meucci G, Vecchi M, Astegiano M, et al. The natural history of ulcerative proctitis: A multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol 2000;95:469-73.
10. Ho GT, Nimmo ER, Tenesa A, et al. Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology 2005;128:288-96.
11. Roussomoustakaki M, Satsangi J, Welsh K, et al. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 1997;112:1845-53.
12. Halfvarson J, Bodin L, Tysk C, et al. Inflammatory bowel disease in a Swedish twin cohort: A long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003;124:1767-73.
13. Cosnes J. Tobacco and IBD: Relevance in the understanding of disease mechanisms and clinical practice. Best Prac Res Clin Gastroenterol 2004;18:481-96.
14. Abraham N, Selby W, Lazarus R, et al. Is smoking an indirect risk factor for the development of ulcerative colitis? An age- and sex-matched case-control study. J Gastroenterol Hepatol 2003;18:139-46.
15. Fraga XF, Vergara M, Medina C, et al. Effects of smoking on the presentation and clinical course of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997;9:683-7.
16. General Household Survey. Liringin Britain Chapter 8: Smoking.Available at: http://www.statistics.gov.uk/lib2002/downloads/smoking.pdf 2002. Accessed 7 Dec 2006.
17. Birrenbach T, Bocker U. Inflammatory bowel disease and smoking: A review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004;10:848-59.
18. Mokbel M, Carbonnel F, Beaugerie L, et al. Effect of smoking on the long-term course of ulcerative colitis. Gastroenterol Clin Biol 1998;22:858-62.
19. Green JT, Rhodes J, Ragunath K, et al. Clinical status of ulcerative colitis in patients who smoke.AmJ Gastroenterol 1998;93:1463-7.
20. Odes HS, Fich A, Reif S, et al. Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis. Dig Dis Sci 2001;46:1717-21.
21. Silicia B, Vicente R, Arroyo MT, et al. Ulcerative pancolitis predicts the need for colectomy: Study of an incident cohort of patients with ulcerative colitis in Aragon (Spain). Gastroenterol Hepatol 2005;28:55-9.
22. Boyko EJ, Perera DR, Koepsell TD, et al. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 1988;23:1147-52.
23. Moum B, Ekbom A, Vatn MH, et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol 1997;32:1005-12.
24. Srivasta ED, Newcombe RG, Rhodes J, et al. Smoking and ulcerative colitis: a community study. Int J Colorectal Dis 1993;8:71-4.
25. Beaugerie L, Massot N, Carbonnel F, et al. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol 2001;96:2113-6.
26. Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994;330:811-5.
27. Corrao G, Tragnone A, Caprilli R, et al. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: A nationwide case-control study. Cooperative investigators of the Italian group for the study of the colon and the rectum (GISC). Int J Epidemiol 1998;27:397-404.
28. Cosnes J, Beaugerie L, Carbonnel F, et al. Smoking cessation and the course of Crohn's disease: An intervention study. Gastroenterology 2001;120:1093-9.
29. Ekbom A. The epidemiology of IBD. A lot of data but little knowledge. How shall we proceed? Inflamm Bowel Dis 2004;10(Suppl 1):S32-4.
30. Piront P, Louis E, Latour P, et al. Epidemiology of inflammatory bowel diseases in the elderly in the province of Liege. Gastroenterol Clin Biol 2002;26:157-61.
31. Regueiro M, Kip KE, Cheung O, et al. Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis 2005;11:42-7.
32. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24:2-6.
33. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19(Suppl A):5A-36A.
34. Bland JM, Altman DG. Statistics notes: The odds ratio. Br Med J 2000;320:1468.
35. Picco MF, Goodman S, Reed J, et al. Methodologic pitfalls in the determination of genetic anticipation: The case of Crohn disease. Ann Intern Med 2001;134:1124-9.
36. Hanauer SB. Update on the etiology, pathogenesis and diagnosis of ulcerative colitis. Nat Clin Prac Gastroenterol Hepatol 2004;1:26-31.
37. Riegler G, Tartaglione MT, Carratu R, et al. Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: A study by GISC (Italican Colon-Rectum Study Group). Dig Dis Sci 2000;45:462-5.
38. Langholz E, Munkholm P, Nielsen OH, et al. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 1991;26:1247-56.
39. Loftus EV Jr, Silverstein MD, Sandborn WJ, et al. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: Incidence, prevalence and survival. Gut 2000;46:336-43.
40. Shivananda S, Lennard-Jones JE, Logan RF, et al. Incidence of inflammatory bowel disease across Europe: Is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (ECIBD). Gut 1996;39:690-7.
41. Loftus EVJr. Clinical epidemiology of Inflammatory bowel disease: Incidence, prevalence and environmental influences. Gastroenterology 2004;128:1504-17.
42. Faybush EM, Blanchard JF, Rawsthorne P, et al. Generational differences in the age at diagnosis with IBD: Genetic anticipation, bias, or temporal effects. Am J Gastroenterol 2002;97:636-40.
43. Cosnes J, Nion-Larmurier I, Afchain P, et al. Gender differences in the response of colitis to smoking. Clin Gastroenterol Hepatol 2004;2:41-8.
44. García Rodríguez LA, González-Pérez A, Johansson S, et al. Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther 2005;22:309-15.
45. Menchén L, Colón AL, Madrigal JLM, et al. Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis. Am J Gastroenterol 2004;99:1756-64.
46. Wei XM, Kim HS, Kumar RK, et al. Effects of cigarette smoke on degranulation and NO production by mast cells and epithelial cells. Respir Res 2005;6:108-16.
47. Eliakim R, Fan QX, Babyatsky MW. Chronic nicotine administration differentially alters jejunal and colonic inflammation in interleukin-10 deficient mice. Eur J Gastroenterol Hepatol 2002;14:607-14.
48. Hawkins BT, Abbruscato TJ, Egleton RD, et al. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res 2004;1027:48-58.
49. Zhang S, Day INM, Ye S. Microarray analysis of nicotine-induced changes in gene expression in endothelial cells. Physiol Genomies 2001;5:187-92.
50. Ingram JR, Routledge P, Rhodes J, et al. Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine. Aliment Pharmacol Ther 2004;20:859-65.
51. Guo X, Wang WP, Ko JK, et al. Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats. Gastroenterology 1999;117:884-92.
52. Guo X, Ko JK, Mei QB, et al. Aggravating effect of cigarette smoke exposure on experimental colitis is associated with leukotriene B(4) and reactive oxygen metabolites. Digestion 2001;63:180-7.
53. Ouyang Y, Virasch N, Hao P, et al. Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts. J Allergy Clin Immunol 2000;106:280-7.
54. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002;2:372-7.